Clinical Nuclear Medicine

Skip Navigation LinksHome > February 2013 - Volume 38 - Issue 2 > Bone Metastases from Prostate Cancer: 18F-Fluoride PET/CT in...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e31827a20d3
Interesting Images

Bone Metastases from Prostate Cancer: 18F-Fluoride PET/CT in a Patient With Discordant Bone Scintigraphy and 11C-Choline PET/CT

Garcia, Garzon Jr MD; Riera, Eduard MD; Valls, Eulalia MD; Soler, Marina MD; Bassa, Pere MD; Moragas, Merce MD; Lomeña, Francisco MD

Collapse Box

Abstract

Abstract: Bone scintigraphy has been used extensively in prostate cancer patients to detect bone involvement.

11C-choline PET/CT is indicated when a biochemical recurrence is suspected, as this procedure is able to detect local recurrence, lymph-node infiltration, and metastases.

In cases where the results of these 2 procedures do not coincide, MRI is then usually performed. 18F-fluoride may become an alternative to MRI for bone imaging.

In our patient series, all bone lesions with 11C-choline uptake were metastases. 18F-Fluoride did not increase specificity of 11C-choline but increased sensitivity of bone scintigraphy. CT helped in the interpretation of osteoarthritis and trauma lesions.

© 2013 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.